We’re transforming wound care with bioactive glass.
Intentional engineering
We lead with compassion, believing that engineering, no matter how advanced, is only as valuable as the people it helps.
Focusing on peace of mind
We aim to deliver safe, effective and efficient wound care solutions that bring providers and patients peace of mind.
Empowering the body to heal itself
We harness the power of elements, engineered as bioactive glass, to offer an unparalleled solution in wound care.
Leadership Team
Nicolas Guggenheim
CEO ETS
Christine Grogan
Head of Wound Care
Steve Jung
Chief Technology Officer
Robert Richter
Chief Financial Officer
Mitch Lark
Chief Operating Officer
Melissa Miller
Head of Human Resources, Compliance Officer
Donnie Buck
Chief Medical Officer
Built to support healing.
Mirragen® is a product of Engineered Tissue Solutions (ETS). a company dedicated to developing medical products composed of proprietary borate-based bioactive glass. Mirragen is the first FDA-cleared inorganic bioactive glass based wound care solution.
ETS was acquired in 2021 by the Heraeus Group, a FORTUNE Global 500 listed and broadly diversified family-owned technology company. Learn more about Heraeus Group at www.heraeus.com.